← FDA DRUG APPROVALS

FDA ANDA · ANDA065194

CLINDAMYCIN HYDROCHLORIDE

Sponsor: EPIC PHARMA LLC

APPLICATION
ANDA065194
TYPE
ANDA
ORIGINAL APPROVAL
2004-03-22
LATEST ACTION
2019-08-19
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Prescription

Products

CLINDAMYCIN HYDROCHLORIDEPrescription
CLINDAMYCIN HYDROCHLORIDE EQ 300MG BASE · CAPSULE · ORAL
CLINDAMYCIN HYDROCHLORIDEPrescription
CLINDAMYCIN HYDROCHLORIDE EQ 150MG BASE · CAPSULE · ORAL

Approval history

2019-08-19Labeling · Supplement 9 · standardAP
2019-08-19Labeling · Supplement 5 · standardAP
2019-08-19Labeling · Supplement 8 · standardAP
2019-08-19Labeling · Supplement 6 · standardAP
2019-08-19Labeling · Supplement 10 · standardAP
2012-02-10Labeling · Supplement 4AP
2006-05-10Labeling · Supplement 2AP
2005-11-14Labeling · Supplement 1AP
2004-03-22OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →